Additionally, indoleamine 2,3-dioxygenase 1 (IDO) expression in tumor cells facilitates the recruitment and activation of immunosuppressive myeloid-derived suppressor cells (MDSCs) to inhibit anti-tumor immunity [11]. Here, IDO1 is linked to neoplasm.